Synaptogenix (SNPX) Stock Chart & Stock Price History $2.97 +0.09 (+3.13%) (As of 12/11/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Synaptogenix Stock Price Performance 5 Day Performance+4.58%1 Month Performance-1.00%3 Month Performance+4.21%6 Month Performance-30.93%Year-To-Date Performance-56.31%1 Year Performance-53.34% Receive SNPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. Email Address Prepare Now Before This Looming $2 Trillion D.C. Shock (Ad)Millions of traders could get blindsided by this election-year shock on December 18th… And if you do nothing now, you could wind up panicking in the next 30 days… or worse, making a costly mistake.Click here to watch his emergency briefing >>> SNPX Stock Chart for Thursday, December, 12, 2024 SNPX Chart by TradingView Synaptogenix Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/11/2024$2.88$2.97+3.13%$2.97$2.894,804 shs$4.03 million12/10/2024$2.94$2.88-2.04%$2.94$2.88803 shs$3.91 million12/09/2024$2.84$2.94+3.52%$3.07$2.8624,515 shs$4.00 million12/06/2024$2.96$2.84-4.05%$2.96$2.806,464 shs$3.85 million12/05/2024$3.03$2.96-2.31%$3.05$2.762,702 shs$4.03 million12/04/2024$2.97$3.03+2.02%$3.13$2.6410,509 shs$4.12 million Get the Latest News and Ratings for SNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. 12/03/2024$3.13$2.97-5.11%$3.14$2.9711,065 shs$4.04 million12/02/2024$2.88$3.13+8.61%$3.15$2.7453,993 shs$4.24 million11/29/2024$2.72$2.88+5.96%$2.89$2.7713,248 shs$3.92 million11/28/2024$2.72$2.72$2.81$2.4960,946 shs$3.70 million11/27/2024$2.72$2.72+0.03%$2.81$2.4960,946 shs$3.70 million11/26/2024$2.71$2.72+0.34%$2.80$2.6010,845 shs$3.70 million11/25/2024$2.60$2.71+4.23%$2.82$2.6515,866 shs$3.69 million11/22/2024$2.57$2.60+1.17%$2.60$2.354,605 shs$3.54 million11/21/2024$2.65$2.57-3.06%$2.60$2.563,256 shs$3.50 million11/20/2024$2.41$2.65+10.00%$2.65$2.4710,425 shs$3.60 million11/19/2024$2.52$2.41-4.37%$2.75$2.417,731 shs$3.28 million11/18/2024$2.40$2.52+5.00%$2.69$2.4322,762 shs$3.43 million11/15/2024$2.61$2.40-8.05%$2.56$2.3222,492 shs$3.25 million11/14/2024$2.74$2.61-4.68%$2.75$2.6014,903 shs$3.55 million11/13/2024$3.00$2.74-8.73%$3.02$2.6534,327 shs$3.72 million11/12/2024$3.15$3.00-4.76%$3.18$3.0011,514 shs$4.07 million11/11/2024$2.95$3.15+6.78%$3.19$2.8923,547 shs$4.27 million Related Companies Aprea Therapeutics Stock Price Chart Cognition Therapeutics Stock Price Chart Akari Therapeutics Stock Price Chart Synlogic Stock Price Chart NRx Pharmaceuticals Stock Price Chart Cara Therapeutics Stock Price Chart Minerva Neurosciences Stock Price Chart TherapeuticsMD Stock Price Chart NKGen Biotech Stock Price Chart Sol-Gel Technologies Stock Price Chart Receive SNPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SNPX) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a ...Investing Daily | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredWant to Start Investing? It’s Easier Than You Think!Many people think you need a lot of money to start investing—but that’s simply not true. Andy Tanner, Rich ...The Cashflow Academy | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWaveBot: The Automated Trading Tool for This Bull MarketThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.